Comparison of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus

Digestive and Liver Disease

Volumn 38, Issue 10, 2006, Pages 724-729

  Gossner, L ^a   Pech, O ^a   May, A ^a   Vieth, M ^b   Stolte, M ^b   Ell, C ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b Institute of Pathology   (Germany)

Author keywords

Barrett's oesphagus; Chromoendoscopy; Oesophageal cancer

Indexed keywords

METHYLENE BLUE;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER GRADING; CANCER PATIENT; CHROMOENDOSCOPY; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY CANCER; ENDOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; STAINING; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; CARCINOMA IN SITU; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; METHYLENE BLUE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33748498681     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.05.025     Document Type: Article

References (29)

1. Spechler S.J., Lee E., Ahnen D., Goyal R.K., Hirano I., Ramirez F., et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. J Am Med Assoc 285 (2001) 2331-2338
2. Shaheen N.J., Crosby M.A., Bozymski E.M., and Sandler R.S. Is there publication bias in the reporting of cancer risk in Barrett's esophagus?. Gastroenterology 119 (2000) 333-338
3. Prach A.T., MacDonald T.A., Hopwood D.A., and Johnston D.A. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology?. Lancet 350 (1997) 933
4. Sampliner R.E., and The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 97 (2002) 1888-1895
5. Dulai G.S., Guha S., Kahn K.L., Gornbein J., and Weinstein W.M. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology 122 (2002) 26-33
6. Corley D.A., Levin T.R., Habel L.A., Weiss N.S., and Buffler P.A. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology 122 (2002) 633-640
7. Kim S.L., Waring J.P., Spechler S.J., Sampliner R.E., Doos W.G., Krol W.F., et al. Diagnostic inconsistencies in Barrett's esophagus: Department of Veterans Affairs Gastroesophageal Reflux Study Group. Gastroenterology 107 (1994) 945-949
8. Levine D.S., Haggitt R.C., Blount P.L., Rabinovitch P.S., Rusch V.W., and Reid B.J. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 104 (1993) 40-50
9. Falk G., Rice T., Goldblum J., and Richter J.E. Jumbo biopsy protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastroenterology 49 (1999) 170-176
10. Canto M.I., Yoshida T., and Gossner L. Chromoendoscopy of intestinal metaplasia in Barrett's esophagus. Endoscopy 34 (2002) 330-336
11. Sharma P., Mayo M., Topalovski M., and Weston A.P. Methylene blue chromoendoscopy for the detection of patients with short segment́s Barrett's esophagus. Gastrointest Endosc 54 (2001) 289-293
12. Canto M.F., Setrakian S., Willis J., Chak A., Petras R., Powe N.R., et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 51 (2000) 560-568
13. Wo J.M., Ray M.B., Mayfield-Stokes S., Al-Sabbagh G., Gebrail F., Slone S.P., et al. Comparison of methylene blue-directed biopsies and conventional biopsies in the detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a preliminary study. Gastrointest Endosc 54 (2001) 294-301
14. Egger K., Werner M., Meining A., Ott R., Allescher H.D., Hofler H., et al. Biopsy surveillance is still necessary in patients with Barrett's esophagus despite new endoscopic imaging techniques. Gut 52 (2003) 18-23
15. Gossner L., Stolte M., Sroka R., Rick K., May A., Hahn E.G., et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 114 (1998) 448-455
16. Ell C., May A., Gossner L., Pech O., Gunter E., Mayer G., et al. Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's esophagus. Gastroenterology 118 (2000) 670-677
17. May A., Gossner L., Behrens A., Kohnen R., Vieth M., Stolte M., et al. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc 58 (2003) 167-175
18. Watanabe H., Jass J.R., and Sobin L.H. Histological typing of oesophageal and gastric tumours. 2nd ed. (1990), Springer, Berlin
19. Pech O., Gossner L., May A., Rabenstein T., Vieth M., Stolte M., et al. Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia. Gastrointest Endosc 62 (2005) 24-30
20. Canto M.F., Setrakian S., Petras R.E., Chak A., Petras R.E., and Sivak M.V. Methylene blue selectively stains intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 44 (1996) 1-7
21. Kiesslich R., Hahn M., Herrmann G., and Jung M. Screening for specialized columnar epithelium with methylene blue: chromoendoscopy for patients with Barrett's esophagus and a normal control group. Gastrointest Endosc 53 (2001) 47-52
22. Breyer H.P., Silva de Barros S.G., Maguilnik I., and Edelweiss M.I. Does methylene blue detect intestinal metaplasia in Barrett's esophagus?. Gastrointest Endosc 57 (2003) 505-509
23. Kouklakis G.S., Kountouras J., Dokas S.M., Molyvas E.J., Vourvoulakis G.P., and Minopoulos G.I. Methylene blue chromoendoscopy for the detection of Barrett's esophagus. Endoscopy 35 (2003) 383-387
24. Ragunath K., Krasner N., Raman V.S., Haqqani M.T., and Cheung W.Y. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus. Endoscopy 35 (2003) 998-1003
25. Mukunda B.R., Mayfield-Stokes S., and Cecil B. Results of methylene blue-directed biopsy is similar to concentional biopsy for the diagnosis of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 49 (1999) AB54
26. Dave U., Shousha S., and Westaby D. Methylene blue staining: is it really useful in Barrett's esophagus?. Gastrointest Endosc 53 (2001) 333-335
27. Weston A.P., Krmpotich P.T., Cherian R., Dixon A., and Topalosvki M. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol 92 (1997) 407-413
28. Olliver J.R., Wild C.P., Sahay P., Dexter S., and Hardie L.J. Chromoendoscopy with methylene blue and associated DNA damage in Barrett's esophagus. Lancet 362 (2003) 373-374
29. Friedberg E.C., Walker G.C., and Siede W. DNA repair and mutagenesis (1995), ASM Press, Washington